AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23502662 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline nebulization
Number of subjects: 100
Study 23502662 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline nebulization
Number of subjects: 100
Study 21679485 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 g oligofructose
Number of subjects: 31
Study 18330657 — intervention group
Group type: EXPERIMENTAL
Intervention: Longo stapled hemorrhoidopexy (SH)
Number of subjects: 171
Study 18330657 — intervention group
Group type: COMPARATOR
Intervention: Milligan-Morgan hemorrhoidectomy (MMH)
Number of subjects: 171
Study 16581486 — intervention group
Group type: EXPERIMENTAL
Intervention: E/e' ratio greater than 15
Number of subjects: 47
Study 16581486 — intervention group
Group type: COMPARATOR
Intervention: E/e' ratio 15 or less
Number of subjects: 47
Study 16581486 — intervention group
Group type: EXPERIMENTAL
Intervention: E/e' ratio
Number of subjects: 47
Study 12488121 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 78
Study 12488121 — intervention group
Group type: EXPERIMENTAL
Intervention: SUPPORT
Number of subjects: 78
Study 12488121 — intervention group
Group type: COMPARATOR
Intervention: Wait List
Number of subjects: 78
Study 10393452 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide in phospholipid liposomes
Number of subjects: 20
Study 10393452 — intervention group
Group type: COMPARATOR
Intervention: Commercial BPO formulation
Number of subjects: 20
Study 10393452 — intervention group
Group type: COMPARATOR
Intervention: Pharmacopoeial BPO formulation
Number of subjects: 20
Study 8891940 — intervention group
Group type: EXPERIMENTAL
Intervention: Quik Floss
Number of subjects: 30
Study 8891940 — intervention group
Group type: COMPARATOR
Intervention: Finger Flossing
Number of subjects: 30
Study 2049819 — intervention group
Group type: EXPERIMENTAL
Intervention: soft lens lubricants
Number of subjects: 30
Study 2049819 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 30
Study 6839799 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline magnesium trisalicylate (3 g)
Number of subjects: 16
Study 6839799 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (2.4 g)
Number of subjects: 16
Study 31025207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30
Study 31025207 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Fractional CO2 laser + topical tioconazole 28% nail lacquer)
Number of subjects: 30
Study 31025207 — intervention group
Group type: COMPARATOR
Intervention: Topical tioconazole 28% nail lacquer
Number of subjects: 30
Study 30119694 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized chronotherapy intervention including individually timed bright light therapy (BLT), bi-weekly tailored physical activity (PA) counseling, and general sleep hygiene education.
Number of subjects: 96
Study 30119694 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (CON)
Number of subjects: 96
Study 27799661 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 38
Study 27799661 — intervention group
Group type: COMPARATOR
Intervention: Shoulder stabilization exercise
Number of subjects: 38
Study 25183511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A-based immunosuppression
Number of subjects: 0
Study 25183511 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus-based immunosuppression
Number of subjects: 0
Study 25183511 — intervention group
Group type: COMPARATOR
Intervention: Comparison of diabetic and normal groups
Number of subjects: 0
Study 25183511 — intervention group
Group type: COMPARATOR
Intervention: NODAT group
Number of subjects: 0
Study 23095790 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 70 mg/m² administered intravenously on day 1 of a 3-week cycle
Number of subjects: 50
Study 19095213 — intervention group
Group type: EXPERIMENTAL
Intervention: Telavancin (10 mg/kg IV every 24 hours)
Number of subjects: 194
Study 19095213 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (1 g IV every 12 hours)
Number of subjects: 194
Study 19095213 — intervention group
Group type: EXPERIMENTAL
Intervention: Telavancin
Number of subjects: 194
Study 19095213 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 194
Study 17947266 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% povidone-iodine eye drops (PIED)
Number of subjects: 2004
Study 17947266 — intervention group
Group type: COMPARATOR
Intervention: Ophthalmic chloramphenicol (OC)
Number of subjects: 2004
Study 15829574 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic monitoring using DAS28
Number of subjects: 384
Study 15829574 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 384
Study 12478035 — intervention group
Group type: EXPERIMENTAL
Intervention: BoneSource hydroxyapatite cement
Number of subjects: 38
Study 12478035 — intervention group
Group type: COMPARATOR
Intervention: Autologous cancellous bone
Number of subjects: 38
Study 10636599 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal cigarette smoke exposure
Number of subjects: 31
Study 10636599 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2 challenge
Number of subjects: 31
Study 10636599 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% O2 challenge
Number of subjects: 31
Study 10636599 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-smoking mothers)
Number of subjects: 31
Study 8722072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (multiple daily injections)
Number of subjects: 29
Study 8722072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (continuous subcutaneous insulin infusion)
Number of subjects: 29
Study 8722072 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 29
Study 2038782 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (20 micrograms)
Number of subjects: 54
Study 2038782 — intervention group
Group type: COMPARATOR
Intervention: Papaverine (60 mg)
Number of subjects: 54
Study 6817944 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg sodium cromoglycate (SCG) powder delivered by Spinhaler
Number of subjects: 16
Study 6817944 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg sodium cromoglycate (SCG) delivered by pressurized aerosol
Number of subjects: 16
Study 6817944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 6817944 — intervention group
Group type: COMPARATOR
Intervention: No pre-treatment
Number of subjects: 16
Study 28981173 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing reflection
Number of subjects: 41
Study 28981173 — intervention group
Group type: COMPARATOR
Intervention: Oral reflection
Number of subjects: 41
Study 26667921 — intervention group
Group type: EXPERIMENTAL
Intervention: AIT followed by DIET (E‐then‐D, n=12)
Number of subjects: 36
Study 26667921 — intervention group
Group type: EXPERIMENTAL
Intervention: AIT concurrent with DIET (E+D, n=12)
Number of subjects: 36
Study 26667921 — intervention group
Group type: COMPARATOR
Intervention: AIT without DIET (E CON, n=12)
Number of subjects: 36
Study 25136791 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly remote monitoring-driven management
Number of subjects: 1650
Study 25136791 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1650
Study 25136791 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring-driven management
Number of subjects: 1650
Study 22392415 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone plus Ginkgo T.D. (80 mg/day for patients under 30 kg and 120 mg/day for patients above 30 kg)
Number of subjects: 47
Study 22392415 — intervention group
Group type: COMPARATOR
Intervention: Risperidone plus placebo
Number of subjects: 47
Study 20819645 — intervention group
Group type: EXPERIMENTAL
Intervention: Transulnar approach (TUA)
Number of subjects: 240
Study 20819645 — intervention group
Group type: COMPARATOR
Intervention: Transradial approach (TRA)
Number of subjects: 240
Study 19156094 — intervention group
Group type: EXPERIMENTAL
Intervention: Local ozone therapy combined with low-frequency magnetic fields (ozonomagnetophoresis)
Number of subjects: 60
Study 19156094 — intervention group
Group type: COMPARATOR
Intervention: Wound irrigation with ozone
Number of subjects: 60
Study 15665884 — intervention group
Group type: COMPARATOR
Intervention: Methadone (mean 106 mg, range 80-160)
Number of subjects: 50
Study 15665884 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (16 mg sublingual)
Number of subjects: 50
Study 12773357 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprotected receptive anal sex in the previous 6 months
Number of subjects: 4295
Study 12773357 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprotected insertive anal sex in the previous 6 months
Number of subjects: 4295
Study 12773357 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprotected anal sex with 1 primary partner or multiple partners
Number of subjects: 4295
Study 12773357 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug and alcohol use
Number of subjects: 4295
Study 10759236 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymosin-alpha1 at a dose of 900 microg/m2 twice a week for six months
Number of subjects: 44
Study 10759236 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 44
Study 10759236 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymosin-alpha1 treatment
Number of subjects: 44
Study 8707562 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette of a patient with schizophrenia
Number of subjects: 0
Study 8707562 — intervention group
Group type: COMPARATOR
Intervention: Vignette of a patient without schizophrenia
Number of subjects: 0
Study 1401090 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised method of conservative palatoplasty
Number of subjects: 21
Study 1401090 — intervention group
Group type: COMPARATOR
Intervention: Perko's mucosal flap operation
Number of subjects: 21
Study 1401090 — intervention group
Group type: COMPARATOR
Intervention: Wardill's mucoperiosteal flap operation
Number of subjects: 21
Study 4042540 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler technique for beat-to-beat measurement of cardiac output
Number of subjects: 25
Study 4042540 — intervention group
Group type: COMPARATOR
Intervention: Thermodilution method
Number of subjects: 25
Study 4042540 — intervention group
Group type: COMPARATOR
Intervention: Nitrous oxide rebreathing method
Number of subjects: 25
Study 3556813 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental alerting tasks (four different tasks)
Number of subjects: 40
Study 3556813 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive listening (as one of the mental alerting tasks)
Number of subjects: 40
Study 29406176 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline 0.9%
Number of subjects: 60
Study 29406176 — intervention group
Group type: COMPARATOR
Intervention: Balanced crystalloid (acetate-buffered)
Number of subjects: 60
Study 27395385 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g/day milk-containing LNS
Number of subjects: 1932
Study 27395385 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g/day milk-containing LNS
Number of subjects: 1932
Study 27395385 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g/day milk-containing LNS
Number of subjects: 1932
Study 27395385 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g/day milk-free LNS
Number of subjects: 1932
Study 27395385 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g/day milk-free LNS
Number of subjects: 1932
Study 27395385 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplement)
Number of subjects: 1932
Study 24122916 — intervention group
Group type: EXPERIMENTAL
Intervention: LIVE-IGS system
Number of subjects: 14
Study 24122916 — intervention group
Group type: COMPARATOR
Intervention: Conventional IGS system
Number of subjects: 14
Study 23301232 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth wipes
Number of subjects: 50
Study 23301232 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrushes
Number of subjects: 50
Study 23301232 — intervention group
Group type: EXPERIMENTAL
Intervention: Gauze
Number of subjects: 50
Study 21079164 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test using Minolta CR‐400 Chromameter
Number of subjects: 46
Study 18996231 — intervention group
Group type: EXPERIMENTAL
Intervention: Body‐weight‐supported treadmill walking for 20 minutes at 70% of estimated heart rate reserve
Number of subjects: 21
Study 18996231 — intervention group
Group type: COMPARATOR
Intervention: 20‐minute review of a home exercise program with a physiotherapist
Number of subjects: 21
Study 15992652 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily, vitamin C 1 g daily, and vitamin E 1,000 U daily
Number of subjects: 1005
Study 15992652 — intervention group
Group type: COMPARATOR
Intervention: Matching placebos
Number of subjects: 1005
Study 12637120 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride (1 mg starting dose, titrated to 2 mg and 4 mg)
Number of subjects: 70
Study 12637120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 10872928 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of 4.0 mg triamcinolone acetonide
Number of subjects: 27
Study 10872928 — intervention group
Group type: COMPARATOR
Intervention: Observation of untreated subjects
Number of subjects: 27
Study 9360685 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin plus netilmycin
Number of subjects: 34
Study 9360685 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin plus ceftazidime
Number of subjects: 34
Study 1319111 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber diet (HFD)
Number of subjects: 9
Study 1319111 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber diet (LFD)
Number of subjects: 9
Study 3897044 — intervention group
Group type: EXPERIMENTAL
Intervention: Low alcohol content beer (80% reduction in alcohol consumption for 6 weeks)
Number of subjects: 46
Study 3897044 — intervention group
Group type: COMPARATOR
Intervention: Normal alcohol consumption (336 ml of ethanol per week)
Number of subjects: 46
Study 3897044 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of alcohol intake
Number of subjects: 46
Study 3897044 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in alcohol consumption from 350 ml to 70 ml per week
Number of subjects: 46
Study 3897044 — intervention group
Group type: EXPERIMENTAL
Intervention: Resumption of normal drinking habits
Number of subjects: 46
Study 30329126 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth‐based intervention delivered through 10 sessions each of 30 minutes over a 12‐week period with a wearable physical activity monitor
Number of subjects: 100
Study 30329126 — intervention group
Group type: COMPARATOR
Intervention: Telehealth‐based education on nonbehavioral aspects of health for the same frequency and duration as the intervention group
Number of subjects: 100
Study 30329126 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth‐based intervention
Number of subjects: 100
Study 28695416 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT constructs (exercise self-efficacy, exercise goal setting, multidimensional outcome expectations)
Number of subjects: 65
Study 28695416 — intervention group
Group type: EXPERIMENTAL
Intervention: MS symptoms (walking limitations, fatigue, depression)
Number of subjects: 65
Study 28695416 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SCT constructs and MS symptoms
Number of subjects: 65
Study 27227290 — intervention group
Group type: EXPERIMENTAL
Intervention: Teflon infusion set in lipohypertrophied tissue
Number of subjects: 20
Study 27227290 — intervention group
Group type: COMPARATOR
Intervention: Teflon infusion set in nonlipohypertrophied tissue
Number of subjects: 20
Study 27227290 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipohypertrophied tissue
Number of subjects: 20
Study 27227290 — intervention group
Group type: COMPARATOR
Intervention: Nonlipohypertrophied tissue
Number of subjects: 20
Study 27227290 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lipohypertrophied and nonlipohypertrophied tissues
Number of subjects: 20
Study 25027194 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized fentanyl (4 μg/kg)
Number of subjects: 90
Study 25027194 — intervention group
Group type: COMPARATOR
Intervention: IV morphine (0.1 mg/kg)
Number of subjects: 90
Study 25027194 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study 21883510 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular aspiration
Number of subjects: 18
Study 21883510 — intervention group
Group type: COMPARATOR
Intervention: Sham aspirations
Number of subjects: 18
Study 20403471 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI treatment at discharge
Number of subjects: 105224
Study 20403471 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI treatment at discharge in patients without heart failure with renal dysfunction
Number of subjects: 105224
Study 17914515 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing of the nasal septum after septoplasty
Number of subjects: 169
Study 17914515 — intervention group
Group type: COMPARATOR
Intervention: Nasal packing
Number of subjects: 169
Study 15643100 — intervention group
Group type: EXPERIMENTAL
Intervention: St. John's wort (SJW) 600-1800 mg for 12 weeks
Number of subjects: 40
Study 15643100 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 40
Study 12354174 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily for 16 weeks
Number of subjects: 3086
Study 12354174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3086
Study 12354174 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 3086
Study 12354174 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with stable angina pectoris (SA)
Number of subjects: 3086
Study 12354174 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin treatment
Number of subjects: 3086
Study 10965249 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with POAG
Number of subjects: 150
Study 10965249 — intervention group
Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 150
Study 9387637 — intervention group
Group type: COMPARATOR
Intervention: Placebo medicine (control)
Number of subjects: 324
Study 1561022 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg.kg‐1 caffeine
Number of subjects: 40
Study 1561022 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg.kg‐1 caffeine
Number of subjects: 40
Study 1561022 — intervention group
Group type: COMPARATOR
Intervention: Placebo (200 mg. methylcellulose)
Number of subjects: 40
Study 2861907 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine (5 mg/day before sleep)
Number of subjects: 24
Study 2861907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 28399620 — intervention group
Group type: EXPERIMENTAL
Intervention: Linolenic‐glutathione conjugate (Lin‐GSH) cream 2% before UVB irradiation
Number of subjects: 10
Study 28399620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 28399620 — intervention group
Group type: EXPERIMENTAL
Intervention: Lin‐GSH cream 2% after irradiation
Number of subjects: 10
Study 28399620 — intervention group
Group type: EXPERIMENTAL
Intervention: Naïve arm (no treatment)
Number of subjects: 10
Study 29354991 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) at Dazhui (GV 14), Mingmen (GV 4), Shenque (CV 8), Guanyuan (CV 4) with current intensity of (14±2) mA
Number of subjects: 89
Study 29354991 — intervention group
Group type: COMPARATOR
Intervention: Simulated TEAS at the same acupoints with current intensity of 1 mA
Number of subjects: 89
Study 25258425 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward walking training (25 min/day, 3 days/week for 3 months)
Number of subjects: 30
Study 25258425 — intervention group
Group type: COMPARATOR
Intervention: Traditional physical therapy
Number of subjects: 30
Study 23921615 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r + RAL
Number of subjects: 210
Study 23921615 — intervention group
Group type: COMPARATOR
Intervention: LPV/r + 2-3 N(t)RTIs
Number of subjects: 210
Study 21527755 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interview using the Barthel Index
Number of subjects: 131
Study 21527755 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face interview using the Barthel Index
Number of subjects: 131
Study 18068523 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 FA supplementation (1 g eicosapentaenoic acid and 0.7 g docosahexaenoic acid daily)
Number of subjects: 56
Study 18068523 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 56
Study 18068523 — intervention group
Group type: COMPARATOR
Intervention: Oxcarbazepine
Number of subjects: 56
Study 17173824 — intervention group
Group type: EXPERIMENTAL
Intervention: Asynchronous teledermatology (SAF)
Number of subjects: 159
Study 17173824 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous teledermatology (VTC)
Number of subjects: 159
Study 17173824 — intervention group
Group type: COMPARATOR
Intervention: Conventional consult (CC)
Number of subjects: 159
Study 12545342 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment
Number of subjects: 0
Study 10869914 — intervention group
Group type: EXPERIMENTAL
Intervention: Rewarming endpoint on CPB: nasopharyngeal and urinary bladder temperatures >/=36.5 degrees C and 34.0 degrees C
Number of subjects: 72
Study 10869914 — intervention group
Group type: COMPARATOR
Intervention: Rewarming endpoint on CPB: nasopharyngeal and urinary bladder temperatures >/=37.5 degrees C and 36.0 degrees C
Number of subjects: 72
Study 10869914 — intervention group
Group type: COMPARATOR
Intervention: Ambient OR temperature 16‐18 degrees C
Number of subjects: 72
Study 10869914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient OR temperature 21‐23 degrees C
Number of subjects: 72
Study 9042685 — intervention group
Group type: EXPERIMENTAL
Intervention: Special one-year treatment including polyvitamins, N-acetylcysteine, and therapeutic BAL every 3 months (n = 10)
Number of subjects: 20
Study 9042685 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 20
Study 8275152 — intervention group
Group type: EXPERIMENTAL
Intervention: One-handed compressions
Number of subjects: 108